Enrofloxacin
Loading...Enrofloxacin Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
WARNINGS:
For use in animals only. The use of this product in cats may result in Retinal Toxicity. Keep out of reach of children.
Avoid contact with eyes. In case of contact, immediately flush eyes with copious amounts of water for 15 minutes. In case of dermal contact, wash skin with soap and water. Consult a physician if irritation persists following ocular or dermal exposure. Individuals with a history of hypersensitivity to quinolones should avoid this product. In humans, there is a risk of user photosensitization within a few hours after excessive exposure to quinolones. If excessive accidental exposure occurs, avoid direct sunlight.
For customer service or to obtain product information, including Material Safety Data Sheet (MSDS), call 1-866-683-0660.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
INDICATIONS:
Enrofloxacin Antibacterial Injectable Solution is indicated for the management of diseases in dogs associated with bacteria susceptible to enrofloxacin.
History
There is currently no drug history available for this drug.
Other Information
DESCRIPTION:
Enrofloxacin is a synthetic chemotherapeutic agent from the class of the quinolone carboxylic acid derivatives. It has antibacterial activity against a broad spectrum of Gram negative and Gram positive bacteria (See Tables I and II). Each mL of injectable solution contains: enrofloxacin 22.7 mg, n-butyl alcohol 30 mg, potassium hydroxide for pH adjustment and water for injection, q.s.
CHEMICAL NOMENCLATURE AND STRUCTURAL FORMULA:
1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid.
Sources
Enrofloxacin Manufacturers
-
Putney, Inc.
![Enrofloxacin Injection, Solution [Putney, Inc.]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Enrofloxacin | Putney, Inc.
DOSAGE AND ADMINISTRATION:
Enrofloxacin Antibacterial Injectable Solution may be used as the initial dose at 2.5 mg/kg. It should be administered intramuscularly (IM) as a single dose, followed by initiation of enrofloxacin tablet therapy.
Enrofloxacin Antibacterial Injectable Solution may be administered as follows:
Weight of AnimalEnrofloxacin Antibacterial Injectable Solution*
2.5 mg/kg
9.1 kg (20 lb) 1.00 mL 27.2 kg (60 lb) 3.00 mL*The initial Enrofloxacin Antibacterial Injectable Solution administration should be followed 12 hours later by initiation of enrofloxacin tablet therapy.
The lower limit of the dose range was based on efficacy studies in dogs where enrofloxacin was administered at 2.5 mg/kg twice daily. Target animal safety and toxicology studies were used to establish the upper limit of the dose range and treatment duration.
-
Boston Synthetics Limited
Enrofloxacin |
-
Medisca Inc.
Enrofloxacin | Medisca Inc.
There is currently no dosage information available for this product. We apologize for any inconvenience.
![Enrofloxacin Powder [Boston Synthetics Limited]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=90c0d534-892e-451b-afb4-acbb4bd065fd&name=enro.jpg)
![Enrofloxacin Powder [Medisca Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=5c70bd20-b6a5-42c9-acf8-30b81a442019&name=MM1.jpg)
Login To Your Free Account